36 Healthcare Stocks Moving In Thursday's Pre-Market Session - Abeona Therapeutics (NASDAQ:ABEO)

Gainers

Helius Medical Tech, Inc. (NASDAQ:HSDT) stock increased by 88.1% to $0.79 during Thursday's pre-market session. The market cap stands at $15.6 million.
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) shares moved upwards by 41.7% to $4.18. The market cap stands at $102.6 million.
Catalyst Biosciences, Inc. (NASDAQ:CBIO) shares surged 27.9% to $6.10. The market cap seems to be at $65.5 million.
Rite Aid, Inc. (NYSE:RAD) stock surged 26.9% to $10.60. The market cap stands at $504.8 million.
Bionano Genomics, Inc. (NASDAQ:BNGO) shares increased by 10.8% to $1.13. The market cap stands at $20.9 million.
Selecta Biosciences, Inc. (NASDAQ:SELB) shares increased by 8.9% to $1.59. The market value of their outstanding shares is at $70.8 million.
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares rose 8.7% to $0.36. The market cap seems to be at $31.0 million.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock increased by 8.0% to $2.84. The market cap stands at $210.9 million. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) stock moved upwards by 8.0% to $96.70. The market cap stands at $1.3 billion. The most recent rating by Cantor Fitzgerald, on December 16, is at Overweight, with a price target of $104.00.
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stock increased by 6.5% to $0.31. The market cap stands at $64.8 million.
ObsEva, Inc. (NASDAQ:OBSV) shares increased by 6.4% to $3.16. The market cap seems to be at $337.6 million. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $40.00.
TherapeuticsMD, Inc. (NASDAQ:TXMD) shares surged 5.4% to $2.44. The market cap seems to be at $721.1 million.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) stock increased by 4.9% to $69.25. The market cap stands at $1.6 billion. The most recent rating by Stifel Nicolaus, on December 19, is at Buy, with a price target of $126.00.
Genfit, Inc. (NASDAQ:GNFT) shares increased by 4.9% to $17.61. The market value of their outstanding shares is at $552.9 million.
Moleculin Biotech, Inc. (NASDAQ:MBRX) stock rose 3.8% to $0.99. The market value of their outstanding shares is at $48.9 million. The most recent rating by Oppenheimer, on October 17, is at Outperform, with a price target of $2.00.
Seattle Genetics, Inc. (NASDAQ:SGEN) stock rose 3.8% to $117.04. The market cap seems to be at $18.4 billion. The most recent rating by Oppenheimer, on December 12, is at Outperform, with a price target of $124.00.
Fortress Biotech, Inc. (NASDAQ:FBIO) stock rose 3.7% to $2.25. The market cap stands at $99.1 million. The most recent rating by B. Riley, on December 18, is at Buy, with a price target of $9.00.
Macrogenics, Inc. (NASDAQ:MGNX) stock increased by 3.5% to $10.95. The market cap seems to be at $463.2 million. The most recent rating by Cantor Fitzgerald, on December 19, is at Overweight, with a price target of $17.00.
Biocept, Inc. (NASDAQ:BIOC) shares rose 2.9% to $0.24. The market cap seems to be at $16.4 million.
Xenetic Biosciences, Inc. (NASDAQ:XBIO) shares increased by 2.6% to $1.59. The market cap stands at $6.8 million.
Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) stock moved upwards by 2.5% to $3.76. The market value of their outstanding shares is at $114.4 million. The most recent rating by Cantor Fitzgerald, on December 17, is at Neutral, with a price target of $7.00.
Epizyme, Inc. (NASDAQ:EPZM) stock moved upwards by 2.0% to $20.50. The market cap stands at $1.0 billion. The most recent rating by Morgan Stanley, on December 06, is at Overweight, with a price target of $22.00.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) shares moved upwards by 1.7% to $1.17. The market cap seems to be at $46.0 million.
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) shares moved upwards by 1.6% to $24.15. The market value of their outstanding shares is at $165.0 million.
Abeona Therapeutics, Inc. (NASDAQ:ABEO) stock surged 1.5% to $4.00. The market value of their outstanding shares is at $120.9 million.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Losers

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares decreased by 25.9% to $0.40 during Thursday's pre-market session. The market value of their outstanding shares is at $43.0 million. The most recent rating by H.C. Wainwright, on October 28, is at Buy, with a price target of $1.20.
Minerva Neurosciences, Inc. (NASDAQ:NERV) stock plummeted 18.3% to $5.63. The market value of their outstanding shares is at $184.9 million. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $20.00.
Zafgen, Inc. (NASDAQ:ZFGN) stock fell 5.3% to $0.68. The market cap seems to be at $27.6 million.
Amarin Corp, Inc. (NASDAQ:AMRN) shares decreased by 2.5% to $20.30. The market cap stands at $5.8 billion. The most recent rating by Stifel, on December 16, is at Hold, with a price target of $26.00.
Ocugen, Inc. (NASDAQ:OCGN) shares declined 2.3% to $0.38. The market value of their outstanding shares is at $19.7 million. The most recent rating by Chardan Capital, on November 27, is at Buy, with a price target of $2.00.
Exicure, Inc. (NASDAQ:XCUR) shares plummeted 2.0% to $2.90. The market value of their outstanding shares is at $256.8 million. The most recent rating by Guggenheim, on November 20, is at Buy, with a price target of $9.00.
Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) stock fell 1.8% to $0.39. The market cap stands at $3.9 million. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
Solid Biosciences, Inc. (NASDAQ:SLDB) shares plummeted 1.6% to $3.90. The market cap seems to be at $508.2 million. The most recent rating by Nomura, on December 18, is at Buy, with a price target of $10.00.
Obalon Therapeutics, Inc. (NASDAQ:OBLN) stock plummeted 1.6% to $1.88. The market cap stands at $12.9 million.
Sesen Bio, Inc. (NASDAQ:SESN) shares plummeted 1.4% to $0.91. The market value of their outstanding shares is at $123.5 million.
Sanofi, Inc. (NASDAQ:SNY) shares decreased by 1.1% to $49.79. The market cap stands at $115.4 billion. According to the most recent rating by Barclays, on December 06, the current rating is at Underweight.